This morning, the UK’s Royal College of Psychiatrists published a Position Statement on psychedelic and related substances (which it calls PARS) for medical use. Here, we briefly unpack the statement, as well as related guidance it published for psychiatrists working on studies of psychedelics. In its report, the Royal College of Psychiatrists (RCPsych) reviews the available evidence…
